187 related articles for article (PubMed ID: 10417137)
1. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.
Falgarone G; Blanchard HS; Riot B; Simonet M; Breban M
Infect Immun; 1999 Aug; 67(8):3773-9. PubMed ID: 10417137
[TBL] [Abstract][Full Text] [Related]
2. Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.
Simmons WA; Taurog JD; Hammer RE; Breban M
Immunogenetics; 1993; 38(5):351-8. PubMed ID: 8344721
[TBL] [Abstract][Full Text] [Related]
3. The effect of an anti-HLA-B27 immune response on CTL recognition of Chlamydia.
Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
J Immunol; 2001 Sep; 167(6):3375-82. PubMed ID: 11544328
[TBL] [Abstract][Full Text] [Related]
4. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice.
Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J
Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558
[TBL] [Abstract][Full Text] [Related]
5. Coordinate involvement of invasin and Yop proteins in a Yersinia pseudotuberculosis-specific class I-restricted cytotoxic T cell-mediated response.
Falgarone G; Blanchard HS; Virecoulon F; Simonet M; Breban M
J Immunol; 1999 Mar; 162(5):2875-83. PubMed ID: 10072536
[TBL] [Abstract][Full Text] [Related]
6. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
[TBL] [Abstract][Full Text] [Related]
7. Breakdown of CTL tolerance to self HLA-B*2705 induced by exposure to Chlamydia trachomatis.
Popov I; Dela Cruz CS; Barber BH; Chiu B; Inman RD
J Immunol; 2002 Oct; 169(7):4033-8. PubMed ID: 12244206
[TBL] [Abstract][Full Text] [Related]
8. Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease.
Simmons WA; Leong LY; Satumtira N; Butcher GW; Howard JC; Richardson JA; Slaughter CA; Hammer RE; Taurog JD
J Immunol; 1996 Feb; 156(4):1661-7. PubMed ID: 8568273
[TBL] [Abstract][Full Text] [Related]
9. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Ugrinovic S; Mertz A; Wu P; Braun J; Sieper J
J Immunol; 1997 Dec; 159(11):5715-23. PubMed ID: 9548516
[TBL] [Abstract][Full Text] [Related]
10. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis.
Duchmann R; May E; Ackermann B; Goergen B; Meyer zum Büschenfelde KH; Märker-Hermann E
Scand J Immunol; 1996 Jan; 43(1):101-8. PubMed ID: 8560188
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
[TBL] [Abstract][Full Text] [Related]
12. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.
Hermann E; Yu DT; Meyer zum Büschenfelde KH; Fleischer B
Lancet; 1993 Sep; 342(8872):646-50. PubMed ID: 8103147
[TBL] [Abstract][Full Text] [Related]
13. A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27.
Chen JH; Kono DH; Yong Z; Park MS; Oldstone MM; Yu DT
J Immunol; 1987 Nov; 139(9):3003-11. PubMed ID: 2444647
[TBL] [Abstract][Full Text] [Related]
14. Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses.
Ringrose JH; Yard BA; Verjans GM; Boog CJ
Clin Rheumatol; 1996 Jan; 15 Suppl 1():79-85. PubMed ID: 8835510
[TBL] [Abstract][Full Text] [Related]
15. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.
Taurog JD; Dorris ML; Satumtira N; Tran TM; Sharma R; Dressel R; van den Brandt J; Reichardt HM
Arthritis Rheum; 2009 Jul; 60(7):1977-84. PubMed ID: 19565478
[TBL] [Abstract][Full Text] [Related]
16. A ribosomal protein of Yersinia pseudotuberculosis having partial epitope identity with HLA-B27.
Gross U; Chen JH; Kono DH; Yu DT
Autoimmunity; 1990; 7(4):267-77. PubMed ID: 1715196
[TBL] [Abstract][Full Text] [Related]
17. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
Qian BF; Tonkonogy SL; Balfour Sartor R
Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
[TBL] [Abstract][Full Text] [Related]
18. Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies.
Hermann E; Fleischer B; Meyer zum Büschenfelde KH
Ann Med; 1994 Oct; 26(5):365-9. PubMed ID: 7530015
[TBL] [Abstract][Full Text] [Related]
19. Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E; Chamberlain JW
Cell Immunol; 2005 Apr; 234(2):110-23. PubMed ID: 16054612
[TBL] [Abstract][Full Text] [Related]
20. CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats.
May E; Dorris ML; Satumtira N; Iqbal I; Rehman MI; Lightfoot E; Taurog JD
J Immunol; 2003 Jan; 170(2):1099-105. PubMed ID: 12517979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
